Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Association of Early Same-Day Posttherapy Whole-Body SPECT/CT Using Visual RECIP 1.0 with Overall Survival During [177Lu]Lu-PSMA-617 Therapy for Metastatic Castration-Resistant Prostate Cancer.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: April 01, 2026
Baseline Hematological Parameters and Outcomes in Patients With Prostate Cancer Treated With Lu-177 PSMA Radioligand Therapy (RLT): A Multicenter Real-World Analysis.
Journal: Clinical genitourinary cancer
Published: December 17, 2025
Same-day post-therapy imaging with a new generation whole-body digital SPECT/CT in assessing treatment response to [177Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer.
Journal: European journal of nuclear medicine and molecular imaging
Published: January 21, 2024
[18F]F-AraG imaging reveals association between neuroinflammation and brown- and bone marrow adipose tissue.
Journal: Communications biology
Published: January 15, 2024
68Ga-RM2 PET-MRI versus MRI alone for evaluation of patients with biochemical recurrence of prostate cancer: a single-centre, single-arm, phase 2/3 imaging trial.
Journal: The Lancet. Oncology
Published: November 21, 2023
Prospective Comparison of 68Ga-NeoB and 68Ga-PSMA-R2 PET/MRI in Patients with Biochemically Recurrent Prostate Cancer.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: November 05, 2023
Analysing the tumor transcriptome of prostate cancer to predict efficacy of Lu-PSMA therapy.
Journal: Journal for immunotherapy of cancer
Published: August 29, 2023
Modified PROMISE criteria for standardized interpretation of gastrin-releasing peptide receptor (GRPR)-targeted PET.
Journal: European journal of nuclear medicine and molecular imaging
Published: April 15, 2023
64Cu-DOTATATE Uptake in a Pulmonary Hamartoma.
Journal: Clinical nuclear medicine
Published: December 05, 2022
The other immuno-PET: Metabolic tracers in evaluation of immune responses to immune checkpoint inhibitor therapy for solid tumors.
Journal: Frontiers in immunology
Published: December 01, 2022
SPECT at the speed of PET: a feasibility study of CZT-based whole-body SPECT/CT in the post 177Lu-DOTATATE and 177Lu-PSMA617 setting.
Journal: European journal of nuclear medicine and molecular imaging
Published: October 21, 2022
Last Updated: 09/26/2026